Epigral Ltd
EPIGRALEpigral Ltd
EPIGRAL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 28.67 | 5.48 | 0.29% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 31.53 | 3.76 | 1.24% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Epigral Limited (formerly Meghmani Finechem Limited) is a manufacturer of essential chemicals, primarily focused on the production of chlor alkali and its derivatives, used across various industries.
Investor Presentation
View olderPeers
Compare with peersSolar Industries India Ltd
Linde India Ltd
Deepak Nitrite Ltd
Castrol India Ltd
Sumitomo Chemical India Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 399.48 | 392.91 | 601.64 | 720.46 | 612.82 | 830.79 | 1,555.05 | 2,196.38 | 1,935.78 | 2,133.49 | ||||||||||
Raw Materials | 178.56 | 175.61 | 235.41 | 256.67 | 279.37 | 386.52 | 759.41 | 1,211.76 | 1,071.60 | 1,563.59 | ||||||||||
| Power & Fuel Cost | 23.74 | 22.91 | 30.89 | 27.46 | 30.27 | 27.93 | 64.15 | 145.56 | 141.32 | |||||||||||
| Employee Cost | 11.96 | 14.08 | 16.27 | 21.38 | 32.72 | 41.26 | 51.99 | 68.85 | 81.31 | |||||||||||
| Selling & Administrative Expenses | 13.18 | 7.97 | 24.46 | 42.15 | 19.76 | 21.35 | 47.85 | 57.01 | 54.12 | |||||||||||
| Operating & Other expenses | 21.41 | 27.42 | 35.21 | 51.05 | 54.26 | 90.22 | 118.06 | 16.30 | 99.64 | |||||||||||
EBITDA | 150.63 | 144.92 | 259.40 | 321.75 | 196.44 | 263.51 | 513.59 | 696.90 | 487.79 | 569.90 | ||||||||||
| Depreciation/Amortization | 44.05 | 55.43 | 55.27 | 54.10 | 44.30 | 73.54 | 85.91 | 108.95 | 123.56 | 126.22 | ||||||||||
| PBIT | 106.58 | 89.49 | 204.13 | 267.65 | 152.14 | 189.97 | 427.68 | 587.95 | 364.23 | 443.68 | ||||||||||
| Interest & Other Items | 18.82 | 14.45 | 8.97 | 25.36 | 11.14 | 29.11 | 44.27 | 65.50 | 73.49 | 69.40 | ||||||||||
| PBT | 87.76 | 75.04 | 195.16 | 242.29 | 141.00 | 160.86 | 383.41 | 522.45 | 290.74 | 374.28 | ||||||||||
| Taxes & Other Items | 20.57 | 8.51 | 39.69 | 59.48 | 28.99 | 60.02 | 130.63 | 169.17 | 94.88 | 124.07 | ||||||||||
| Net Income | 67.19 | 66.53 | 155.47 | 182.81 | 112.01 | 100.84 | 252.78 | 353.28 | 195.86 | 250.21 | ||||||||||
| EPS | 9.50 | 9.40 | 21.97 | 32.66 | 27.07 | 24.27 | 60.84 | 85.02 | 47.14 | 60.22 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 | 5.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.00 |
Company Updates
Annual report
PDFPeers & Comparison
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Epigral Ltd | 36.62 | 5.48 | 0.29% |
| Solar Industries India Ltd | 110.36 | 26.92 | 0.08% |
| Linde India Ltd | 158.18 | 19.80 | 0.15% |
| Deepak Nitrite Ltd | 49.67 | 8.35 | 0.25% |
Price Comparison
Compare EPIGRAL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding Epigral Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Motilal Oswal Nifty Microcap 250 Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0325% | Percentage of the fund’s portfolio invested in the stock 0.23% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 231/255 (-5) |
Groww Nifty Total Market Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0002% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 676/756 (-10) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 2, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Jul 2, 2024
Cash Dividend
Ex DateEx DateJun 20, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Jun 20, 2023
Cash Dividend
Ex DateEx DateFeb 1, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Feb 1, 2023
Revenue from operations jumped 43% to Rs 651.20 crore in Q1 FY25 from Rs 454.89 crore posted in Q1 FY24. Profit before tax (PBT) soared to Rs 130.96 crore in Q1 FY25 as compared with Rs 47.41 crore in Q1 FY24. EBITDA stood at Rs 176 crore as against Rs 95 crore in Q1FY24, resgitering the growth of 85% YoY. EBIDTA margin stood at 27% in Q1FY25 as compared with 21% in Q1FY24 on account of increase in utilization and volume contribution from new projects commissioned. Volume grew 29% YoY and 14% QoQ. Major growth comes from Derivatives this growth is primarily attributed to efficient utilization of capacities and also volume from new projects commissioned. Revenue contribution from Derivatives & Specialty business rose sharply and stood at 53% in Q1FY25 vs 37% in Q1FY24. In the April to June 2024 quarter, we commissioned CPVC Resin and Compound facility and by the end of current quarter we expect to commission Chlorotoluenes Value Chain facility, both these projects will drive growth for Epigral in FY2025 and FY2026. We are moving in line with our long term vision to become fully integrated complex catering to diversified industries and grow consistently to create value for our stakeholders.' Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India. The company is the first to set up an Epichlorohydrin plant in the country and is also the largest capacity plant of CPVC Resin. Epigral is also India's fourth largest manufacturer of caustic soda, chlorine and hydrogen and a leading manufacturer of caustic potash, chloromethanes and hydrogen peroxide. The scrip hit a 52 week high at Rs 1,720 in today's intra-day session. Powered by Capital Market - Live
Net profit of Epigral rose 172.52% to Rs 85.87 crore in the quarter ended June 2024 as against Rs 31.51 crore during the previous quarter ended June 2023. Sales rose 43.16% to Rs 651.20 crore in the quarter ended June 2024 as against Rs 454.89 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales651.20454.89 43 OPM %27.0720.89 - PBDT164.4178.21 110 PBT130.9647.41 176 NP85.8731.51 173 Powered by Capital Market - Live
Epigral will hold a meeting of the Board of Directors of the Company on 24 July 2024.Powered by Capital Market - Live
Meghmani Finechem shines on commissioning of wind-solar power plant
Meghmani Finechem shares snap 2-day fall, surge 15% today amid heavy volumes
Meghmani Finechem shares rise 15% after firm fixes record date for final dividend
Meghmani Finechem shares plunge 5%, hit sub-Rs 1,000 level in knee-jerk reaction to Q4 results
ETMarkets Management Talk: Meghmani Finechem likely to end FY23 with topline of Rs 2,200 cr, says CMD Maulik Patel
National Standard (India) Ltd leads losers in ‘A’ group
Meghmani Finechem debuts in MSCI India Domestic Small Cap Index
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 21.86%, vs industry avg of 9.2%
Increasing Market Share
Over the last 5 years, market share increased from 0.82% to 1.69%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 1.39%, vs industry avg of 3.23%